Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01198535
What this trial is testing

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Who this might be right for
Colon Mucinous AdenocarcinomaColon Signet Ring Cell AdenocarcinomaRectal Mucinous Adenocarcinoma+7 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT00397878
What this trial is testing

AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+3 more
National Cancer Institute (NCI) 10
Large-scale testing (Phase 3)Looking for participantsNCT07462143
What this trial is testing

A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Colorectal (Colon or Rectal) Cancer
RemeGen Co., Ltd. 80
Testing effectiveness (Phase 2)Ended earlyNCT00541112
What this trial is testing

Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

Who this might be right for
Colorectal Cancer
UNICANCER 19
Large-scale testing (Phase 3)Study completedNCT00064181
What this trial is testing

Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC 86
Large-scale testing (Phase 3)Study completedNCT00026117
What this trial is testing

Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer

Who this might be right for
Breast CancerColorectal Cancer
Alliance for Clinical Trials in Oncology 88
Testing effectiveness (Phase 2)Looking for participantsNCT07529808
What this trial is testing

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

Who this might be right for
Gastric CancerGastric AdenocarcinomaGastric (Stomach) Cancer+11 more
BigHat Biosciences, Inc. 164
Testing effectiveness (Phase 2)Looking for participantsNCT03919461
What this trial is testing

Colorectal Metastasis Prevention International Trial 2

Who this might be right for
Colorectal Neoplasms
Assaf-Harofeh Medical Center 200
Large-scale testing (Phase 3)UnknownNCT00006479
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT00005833
What this trial is testing

S9923 R115777 in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network 62
Testing effectiveness (Phase 2)Study completedNCT03086538
What this trial is testing

Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy

Who this might be right for
Colo-rectal Cancer
Samsung Medical Center 29
Testing effectiveness (Phase 2)UnknownNCT03418558
What this trial is testing

Study of Trastuzumab-emtansine in Patients With HER2-positive Metastatic Colorectal Cancer Progressing After Trastuzumab and Lapatinib.

Who this might be right for
Metastatic Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 13
Early research (Phase 1)Study completedNCT00004042
What this trial is testing

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Early research (Phase 1)Study completedNCT00138177
What this trial is testing

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage III Colon Cancer+4 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00587964
What this trial is testing

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Who this might be right for
Brain MetastasisBladder CancerBreast Cancer+10 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT00026299
What this trial is testing

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Chicago 14
Testing effectiveness (Phase 2)Looking for participantsNCT06682793
What this trial is testing

Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more
A2 Biotherapeutics Inc. 240
Testing effectiveness (Phase 2)Study completedNCT01206530
What this trial is testing

FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

Who this might be right for
Rectal CancerColon CancerMetastasis+1 more
Abramson Cancer Center at Penn Medicine 50
Testing effectiveness (Phase 2)UnknownNCT04296019
What this trial is testing

Fruquintinib as a Maintenance Therapy Following First-line Treatment for Metastatic Colorectal Cancer

Who this might be right for
Colo-rectal Cancer
Shanghai Zhongshan Hospital 110
Next Page